Logo for Oryzon Genomics S.A.

Oryzon Genomics Investor Relations Material

Latest events

Logo for Oryzon Genomics

Q4 2024

27 Feb, 2025
Logo for Oryzon Genomics

Q3 2024

24 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Oryzon Genomics S.A.

Access all reports
Oryzon Genomics S.A. is a Spain-based clinical-stage biopharmaceutical company focused on the discovery and development of epigenetic therapies. The company develops small molecule inhibitors targeting specific enzymes involved in gene expression regulation, with therapeutic programs in oncology and neurodegenerative diseases. Oryzon conducts both preclinical and clinical trials and collaborates with academic and industry partners to advance its drug candidates. The company is headquartered in Barcelona, Spain, and its shares are listed on the BME.